Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community
- 1 June 2007
- Vol. 62 (6), 496-592
- https://doi.org/10.1136/thx.2006.064709
Abstract
Background: Despite national disease management plans, optimal asthma management remains a challenge in Australia. Community pharmacists are ideally placed to implement new strategies that aim to ensure asthma care meets current standards of best practice. The impact of the Pharmacy Asthma Care Program (PACP) on asthma control was assessed using a multi-site randomised intervention versus control repeated measures study design. Methods: Fifty Australian pharmacies were randomised into two groups: intervention pharmacies implemented the PACP (an ongoing cycle of assessment, goal setting, monitoring and review) to 191 patients over 6 months, while control pharmacies gave their usual care to 205 control patients. Both groups administered questionnaires and conducted spirometric testing at baseline and 6 months later. The main outcome measure was asthma severity/control status. Results: 186 of 205 control patients (91%) and 165 of 191 intervention patients (86%) completed the study. The intervention resulted in improved asthma control: patients receiving the intervention were 2.7 times more likely to improve from ‘‘severe’’ to ‘‘not severe’’ than control patients (OR 2.68, 95% CI 1.64 to 4.37; p<0.001). The intervention also resulted in improved adherence to preventer medication (OR 1.89, 95% CI 1.08 to 3.30; p = 0.03), decreased mean daily dose of reliever medication (difference -149.11 μg, 95% CI - 283.87 to - 14.36; p = 0.03), a shift in medication profile from reliever only to a combination of preventer, reliever with or without long-acting ß agonist (OR 3.80, 95% CI 1.40 to 10.32; p = 0.01) and improved scores on risk of non-adherence (difference - 0.44, 95% CI - 20.69 to 20.18; p = 0.04), quality of life (difference - 0.23, 95% CI - 0.46 to 0.00; p = 0.05), asthma knowledge (difference 1.18, 95% CI 0.73 to 1.63; p, <.01) and perceived control of asthma questionnaires (difference - 1.39, 95% CI - 2.44 to - 0.35; p<0.01). No significant change in spirometric measures occurred in either group. Conclusions: A pharmacist-delivered asthma care programme based on national guidelines improves asthma control. The sustainability and implementation of the programme within the healthcare system remains to be investigatedKeywords
This publication has 29 references indexed in Scilit:
- Stability of the EasyOne ultrasonic spirometer for use in general practiceRespirology, 2006
- Multilevel modelling of medical dataStatistics in Medicine, 2002
- Effectiveness of Pharmacist Care for Patients With Reactive Airways DiseaseJAMA, 2002
- Asthma management: how effective is it in the community?Internal Medicine Journal, 2002
- Self-management education and regular practitioner review for adults with asthmaCochrane Database of Systematic Reviews, 2002
- Inadequate use of asthma medication in the united states: Results of the asthma in america national population surveyJournal of Allergy and Clinical Immunology, 2002
- Assessment of a Community Pharmacy‐Based Program for Patients with AsthmaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- Asthma programme in Finland: a community problem needs community solutionsThorax, 2001
- A Self-Management Program for Adult Asthma. III. Maintenance and Relapse of SkillsJournal of Asthma, 2001
- Changing Approaches to Asthma Management in AustraliaDrugs, 2001